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Introduction
The impacts associated with hospital-acquired infections
in developing countries are poorly understood, which is
largely due to a lack of reliable primary data [1].
Objectives
Following publication of a major study of paediatric
nosocomial bacteraemia in a single hospital in Kenya
[2], we aim to make a preliminary estimate of the mor-
tality burden associated with this disease in sub-Saharan
Africa.
Methods
Using data on hospital admissions, per admission risk of
disease and associated mortality from Kilifi Hospital,
Kenya in 2005 and combining these with contempora-
neous regional population estimates, we can make a first
estimate of the number of deaths attributable to hospi-
tal-acquired bacteraemia in African children.
Results
Based on this approach, we suggest that approximately
20,000 deaths in children under 5yrs might have occurred
in sub-Saharan Africa in 2005 due to hospital-acquired
bacteraemia. However, due to the inherent insensitivity of
blood cultures for detecting bacteraemia in children, this
might be a substantial underestimate.
Conclusion
Hospital-acquired bacteraemia in developing countries
could have a substantial mortality burden and further
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